SignalPath raises $18m ahead of trial management platform expansion

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags: SignalPath, Data management, Clinical data management, Clinical trial data

SignalPath announced the closing of its Series B funding round to support the expansion of its software platform, which facilitates clinical trials management.

SignalPath, a North Carolina, US-based software developer, has raised $18m (€16.18m) from existing investors, bringing its total capital to $35m (€31.46m), in order to support the expansion of its suite of tools available for clinical trial sites.

The company holds a software platform with tools allowing clinical data storage and management, with an aim to “reduce complexity, drive efficiency, improve quality, and increase transparency across the research ecosystem,”​ according to Brad Hirsch, the company’s CEO.

To date, approximately 250 clinical sites have access to the platform, with the volume of the network ultimately allowing the company to move on to developing insights about clinical research, a project which was previously ‘impossible to conduct’, Hirsch stated.

The funding is expected to support the development of software tools providing these insights, as well as to enable the growth of the company’s research teams.

In 2018, the company announced the launch of a research consortium, with the aim of bringing together technology companies, sponsors and researchers.

The company’s CEO told us then​ that the company aims to have integrated the use of real world data in clinical study design and management by 2020.

Related topics: Clinical Development, Data management

Related news

Show more

Related products

show more

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us


View more